Platinum compounds in children with cancer: toxicity and clinical management

Medicine and Dentistry

• Antineoplastic Activity 16%
• Bone Marrow 16%
• Bone Marrow Suppression 16%
• Brain Tumor 16%
• Carboplatin 50%
• Child 33%
• Cisplatin 66%
• Clinical Management 16%
• Emetic Agent 16%
• Ganglioglioma 16%
• Ganglioneuroblastoma 16%
• Germinoma 16%
• Hepatoblastoma 16%
• Lymphoma 16%
• Malignant Neoplasm 33%
• Mechanism of Action 16%
• Medulloblastoma 16%
• Nausea and Vomiting 16%
• Neurotoxicity 16%
• Osteosarcoma 16%
• Oxaliplatin 50%
• Patient 33%
• Pediatric Cancer 50%
• Pharmacokinetics 33%
• Physician 16%
• Platinum 16%
• Platinum Derivative 100%
• Quality of Life 33%
• Retinoblastoma 16%
• Therapeutic Procedure 16%
• Toxicity 83%

Pharmacology, Toxicology and Pharmaceutical Science

• Bone Marrow Suppression 16%
• Brain Tumor 16%
• Carboplatin 50%
• Cisplatin 66%
• Germ Cell Tumor 16%
• Glioma 16%
• Hepatoblastoma 16%
• Lymphoma 16%
• Malignant Neoplasm 33%
• Medulloblastoma 16%
• Nausea and Vomiting 16%
• Neuroblastoma 16%
• Neurotoxicity 16%
• Osteosarcoma 16%
• Oxaliplatin 50%
• Pharmacokinetics 33%
• Platinum 16%
• Platinum Derivative 100%
• Retinoblastoma 16%
• Toxicity 83%